News ASCO: Rare Eye Cancer Yields to Targeted Drug by MedPage Today • 2013/06/02 • 0 Comments CHICAGO (MedPage Today) -- The novel kinase inhibitor selumetinib may be the first treatment to shrink advanced uveal melanoma, based on phase II trial results. Full Story →